WEBSITECHANGES

Website Changes

---

05/16/2021

GT Medical Technologies Announces First Patient Has Been Enrolled In Clinical Trial Evaluating GammaTile® Therapy In Patients With Metastatic Brain Tumors

---

05/11/2021

Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment

---

05/11/2021

Foucused Ultrasound Webinar added to our video library!

---

05/09/2021

National Walks To End Brain Tumors

---

05/09/2021

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study

---

05/09/2021

Focused Ultrasound Webinar Tonight! (Sunday 5/9/21)

---

05/09/2021

Focused Ultrasound Webinar now posted to website!

---

05/08/2021

Medicenna posts positive data from mid-stage brain cancer study

---

05/08/2021

Dabrafenib-trametinib combination active in BRAF V600E-mutant glioma

---

05/08/2021

Immunotherapy for hard-to-treat cancers ready to move toward clinical trials

---

05/06/2021

Brain Tumor Awareness Month Webinars continues this Sunday, May 9, 2021 with: Current Status and Future Directions of Focused Ultrasound for Brain Tumors

---

05/04/2021

The efficacy of dendritic cell vaccine for newly diagnosed glioblastoma: a meta-analysis of randomized controlled studies

---

05/02/2021

Brain Tumor Awareness Month Webinars Start tonight (Sunday May 2, 2021)!

---

04/29/2021

Brain Tumor Awareness Month Webinars!

---

04/29/2021

xCures launches xACCESS for Providers

---

04/25/2021

Curing Benign Paroxysmal Positional Vertigo in Patients With Brain Tumor: Case Series and Literature Review

---

04/23/2021

Musella Foundation Copay Program now closed to new and renewal patients

---

04/23/2021

10th Annual National Walk to End Brain Tumors and Silent Auction

---

04/22/2021

IQAI commits to Phase1 study for drug candidate in the treatment of Glioblastoma (GBM), a grade IV brain tumor

---

04/22/2021

Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas

---

04/20/2021

Novel CAR-T shows ‘promising early signs of clinical efficacy’ for diffuse midline gliomas

---

04/19/2021

Modified RANO (mRANO), iRANO, and standard RANO response to convection-enhanced delivery of IL4R-targeted immunotoxin MDNA55 in recurrent glioblastoma

---

04/15/2021

Treovir’s Oncolytic Virus Product Extends Survival in Children With Brain Tumors

---

04/14/2021

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

---

04/12/2021

Treovir Announces Positive Results of Phase 1 Study of G207 in Pediatric Patients with Recurrent High-Grade Glioma

---